Purchase Order 75N91018P00648
Award Date 8/27/18
Potential Completion Date 10/31/18
Potential Value $5.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute issued a purchase order to Duke University valued at $3,360.05 on September 26, 2013, for training and tuition services. Performance is located in Durham, North Carolina. The order is firm fixed price with an ultimate completion date of September 30, 2013.</p>
- <p>The National Cancer Institute awarded a purchase order to Metabolon, Inc. valued at $9,750.00 for metabolome screening of CD4+T cell subsets in a pre-clinical model of chronic graft-versus-host disease across 30 samples. The order was issued on April 18, 2018, with an ultimate completion date of April 22, 2018. Performance takes place in Morrisville, North Carolina. The contract is firm fixed price with no set-aside designation.</p>
- <p>The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $146,900.04 to measure metabolomics markers related to pancreatic cancer in human serum samples, with an award date of July 5, 2015 and completion date of January 31, 2017. Work is performed in Durham, North Carolina. The purchase order represents a de-obligation of funds from an expiring FY2015 line and carries firm fixed-price terms with no set-aside designation.</p>
- The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $14,200 on May 24, 2019, with completion by August 1, 2019. The order is firm fixed price with no set-aside designation. Metabolon will deliver a relative concentration profile of small-molecule entities (endogenous compounds, xenobiotics, and metabolites) extracted from 40 cell pellets and detected via the HD4 global metabolomics platform, provided as an Excel file. The awardee will supply an outline of analytical...
- <p>The National Cancer Institute awarded a purchase order to Duke University for $10,000.00 on July 26, 2017, for analysis services. The order carried no set-aside designation and was priced on a firm fixed price basis. Work is performed at Duke's Office of Research Administration in Rockville, Maryland. The order is due for completion by August 30, 2018.</p>
- <p>The National Cancer Institute awarded a purchase order to Duke University for $8,052.00 on September 29, 2010, for brain tumor pathology testing for three patients at $775 per patient less an $80 payment in FY06.</p> <p>Work is performed in Durham, North Carolina. The order is firm fixed price with no set-aside designation. Ultimate completion date is September 29, 2010.</p>
- The National Cancer Institute awarded a purchase order to Metabolon, Inc. for laboratory testing services on July 27, 2017, with a ceiling value of $15,500.00 and a completion date of July 31, 2018. Work is performed in Durham, North Carolina. Metabolon is a self-certified small disadvantaged business providing metabolomic analysis and profiling services using advanced analytical techniques including ultra-high performance liquid chromatography and tandem mass spectrometry. The purchase order...
- The National Cancer Institute awarded a $16,000 purchase order to Metabolon, Inc. for custom metabolomics services on July 25, 2017, with completion on July 25, 2018. Work is performed in Durham, North Carolina. The order is firm fixed price with no set-aside designation. Metabolon is a self-certified small disadvantaged business specializing in metabolomic profiling and analysis using advanced chromatography and mass spectrometry techniques across biological sample types including plasma,...
- <p>The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $55,450 on July 1, 2020, for metabolome analysis of human fresh-frozen breast samples, xenograft tissues, and cell pellets associated with breast cancer metabolism in the context of diabetes and stress. Performance takes place in Morrisville, North Carolina, and the order completes September 30, 2020. The awardee is a self-certified small disadvantaged business. No set-aside was used.</p>
- <p>The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $18,460.00 on June 13, 2019, with final completion on July 13, 2019. The order procures a quality-controlled metabolite data set in Excel format listing every structurally named metabolite identified and relative abundance for 52 human breast tissues. Work is performed in Bethesda, Maryland. Firm fixed price, no set-aside used.</p>
The National Cancer Institute awarded a purchase order to Duke University for $5,760.00 on August 27, 2018 for metabolite profiling of T cells. Place of performance is Durham, North Carolina. The order carries a firm fixed price structure with an ultimate completion date of October 31, 2018.
Generated 8/1/26, 10:41 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 8/26/18 |